Symbio Congress 2022
„Microbial therapy – next level precision probiotics“ – that was the subject of the 5th Symbio congress on November 5, 2022. The congress offered exciting specialist lectures dealing with the new generation of probiotics. Precision probiotics are products containing selected strains of bacteria with precisely defined effects and targeted application.
The focus of the Symbio congress was on gut flora-based prevention of diabetes type 2 and its associated obesity. Here, it is beneficial to take advantage of the targeted effects of selected bacterial strains.
Again, the Symbio congress 2022 took place as an online event. Here, with more than 850 participants, a new record was set. This time, the lectures were transmitted from the company's own film studio in Herborn.
The congress was moderated by Professor Dr. Andreas Schwiertz, MVZ Institute for Microecology and part-time professor at Justus Liebig University Giessen.
On this page you will find the contents of the lectures:
© Dr. Marie-Christine Simon / SymbioPharm
Video recording of the lecture by Professor Dr. Marie-Christine Simon: Metabolic Derailment - The Role of the Microbiome in the Development of Type 2 Diabetes and Obesity
© Pierre Déchelotte / SymbioPharm
Video recording of the lecture by Professor Pierre Déchelotte: Weight reduction through precision probiotics
© Dr. Heike tom Dieck / SymbioPharm
Video recording of the lecture by Dr. Heike tom Dieck: A Next-level Approach: Innovative Synbiotic for Blood Glucose Management
© Dr. Christiane Gras/SymbioPharm